Pular para o conteúdo
· Preenchimentos dérmicos
SKU 11112

Revanesse Outline™+

Em stock
Volume
2 x 1,2 mL
Laboratório
Prollenium Medical Technologies Inc.
Origem
Canadá
Indicação
Deep tissue volume creation and lip structuring
O preço profissional e o histórico são exclusivos de contas verificadas
allpara fornece profissionais licenciados. Inicie sessão ou peça uma conta B2B para ver os preços em tempo real, os escalões por volume e o histórico de preços.

Revanesse Outline+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, designed to treat medium to deep facial rhytides and lipoatrophy. It is placed in the middle part of the dermis layer, where its implantation life averages 6 to 12 months. Its composition is 25 mg/mL of hyaluronic acid cross-linked with BDDE and 0.3% lidocaine in phosphate-buffered saline, for professional use. Each box contains two 1.2 mL syringes with up to two sterilised needles, and Outline+ comes in both a 27G and a 29G needle version.

Principais vantagens de Revanesse Outline™+

  • Cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine for injection comfort
  • Indicated for medium to deep facial rhytides and for lipoatrophy
  • Placed in the middle part of the dermis layer
  • Implantation life averages 6 to 12 months
  • Supplied in both a 27G and a 29G needle version
  • Two 1.2 mL pre-filled syringes per box
  • CE marked 0653 for the syringe, with CE 0123 needles
Informação essencial
Marca REVANESSE
Fabricante Prollenium Medical Technologies Inc.
País de origem Canada
Certificação CE marked 0653 for the syringe. The needles supplied are CE marked 0123.
Composição Cross-linked hyaluronic acid 25 mg/mL; lidocaine 0.3% w/w; in phosphate-buffered saline. Cross-linked with butanediol diglycidyl ether (BDDE).
Volume / Tamanho 1.2 ml
Embalagem 2 pre-filled syringes x 1.2 mL, with up to two sterilised needles. Supplied in a 27G needle version and a 29G needle version.
Tamanho da agulha 27G or 29G, up to two supplied
Tipo de utilização For professional use - injectable dermal filler with lidocaine, injected only by or under the direct supervision of qualified physicians trained in the technique for filling facial wrinkles
Profundidade de injeção Middle part of the dermis layer
Protocolo / Duração Implantation life averages 6 to 12 months, depending on the depth and location of injection

Indicações e utilização profissional

Principais indicações

  • Medium to deep facial rhytides
  • Lipoatrophy

Utilização profissional

For professional use. Revanesse Outline+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is placed in the middle part of the dermis layer. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand, prime the syringe until a small drop appears at the needle tip, and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, and must not contact quaternary ammonium salts such as benzalkonium chloride. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.

Zonas de tratamento

  • Face

Perfil do paciente

For adult patients seeking correction of medium to deep facial rhytides or of lipoatrophy, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.

Como funciona Revanesse Outline™+ ​

Revanesse Outline+ is a cross-linked hyaluronic acid gel that occupies volume in the dermis where it is placed, correcting medium to deep rhytides and the volume loss of lipoatrophy. Because it is placed in the middle part of the dermis rather than superficially, how long it lasts depends on the depth and location of the injection, which is why it lasts 6 to 12 months rather than a fixed period. The 0.3% lidocaine is present for injection comfort, which makes hypersensitivity to amide-type anaesthetics an outright contraindication.

Porquê encomendar na Allpara

A Allpara oferece produtos REVANESSE originais e verificados de fornecedores selecionados, com rastreabilidade total dos lotes e apoio especializado. Servimos clínicas e profissionais de estética com produtos com certificação CE, entrega rápida em toda a UE a partir do nosso armazém na UE e preços profissionais competitivos. A nossa prioridade é a segurança, a satisfação e os resultados dos seus pacientes, com apoio pós-venda dedicado para a sua tranquilidade.

Perguntas frequentes

What is the difference between the 27G and 29G versions of Outline+?

The gel is identical: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes per box, placed in the middle part of the dermis. Only the supplied needle differs, so the choice is a matter of the practitioner's preferred gauge for the area being treated.

How does Outline+ differ from Shape+ and Contour+?

Very little on paper. All three carry 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, are placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, and last 6 to 12 months. Outline+ is the one offered with a 29G needle option.

Mais de Prollenium Medical Technologies

Ver laboratório

Alternativas para a clínica

Todos os produtos

Revanesse Outline™+

Em stock
Marcação CE Marcação CE Revanesse Outline™+
Preços exclusivos para contas verificadas
Inicie sessão ou peça uma conta B2B para ver o seu preço.
Pedir conta B2B

Revanesse Outline+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, designed to treat medium to deep facial rhytides and lipoatrophy. It is placed in the middle part of the dermis layer, where its implantation life averages 6 to 12 months. Its composition is 25 mg/mL of hyaluronic acid cross-linked with BDDE and 0.3% lidocaine in phosphate-buffered saline, for professional use. Each box contains two 1.2 mL syringes with up to two sterilised needles, and Outline+ comes in both a 27G and a 29G needle version.

Principais vantagens de Revanesse Outline™+

  • Cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine for injection comfort
  • Indicated for medium to deep facial rhytides and for lipoatrophy
  • Placed in the middle part of the dermis layer
  • Implantation life averages 6 to 12 months
  • Supplied in both a 27G and a 29G needle version
  • Two 1.2 mL pre-filled syringes per box
  • CE marked 0653 for the syringe, with CE 0123 needles
Informação essencial
Marca REVANESSE
Fabricante Prollenium Medical Technologies Inc.
País de origem Canada
Certificação CE marked 0653 for the syringe. The needles supplied are CE marked 0123.
Composição Cross-linked hyaluronic acid 25 mg/mL; lidocaine 0.3% w/w; in phosphate-buffered saline. Cross-linked with butanediol diglycidyl ether (BDDE).
Volume / Tamanho 1.2 ml
Embalagem 2 pre-filled syringes x 1.2 mL, with up to two sterilised needles. Supplied in a 27G needle version and a 29G needle version.
Tamanho da agulha 27G or 29G, up to two supplied
Tipo de utilização For professional use - injectable dermal filler with lidocaine, injected only by or under the direct supervision of qualified physicians trained in the technique for filling facial wrinkles
Profundidade de injeção Middle part of the dermis layer
Protocolo / Duração Implantation life averages 6 to 12 months, depending on the depth and location of injection

Indicações e utilização profissional

Principais indicações

  • Medium to deep facial rhytides
  • Lipoatrophy

Utilização profissional

For professional use. Revanesse Outline+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is placed in the middle part of the dermis layer. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand, prime the syringe until a small drop appears at the needle tip, and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, and must not contact quaternary ammonium salts such as benzalkonium chloride. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.

Zonas de tratamento

  • Face

Perfil do paciente

For adult patients seeking correction of medium to deep facial rhytides or of lipoatrophy, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.

Como funciona Revanesse Outline™+ ​

Revanesse Outline+ is a cross-linked hyaluronic acid gel that occupies volume in the dermis where it is placed, correcting medium to deep rhytides and the volume loss of lipoatrophy. Because it is placed in the middle part of the dermis rather than superficially, how long it lasts depends on the depth and location of the injection, which is why it lasts 6 to 12 months rather than a fixed period. The 0.3% lidocaine is present for injection comfort, which makes hypersensitivity to amide-type anaesthetics an outright contraindication.

Porquê encomendar na Allpara

A Allpara oferece produtos REVANESSE originais e verificados, com rastreabilidade total dos lotes, stock com certificação CE, entrega rápida em toda a UE e apoio pós-venda especializado.

Perguntas frequentes

What is the difference between the 27G and 29G versions of Outline+?

The gel is identical: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes per box, placed in the middle part of the dermis. Only the supplied needle differs, so the choice is a matter of the practitioner's preferred gauge for the area being treated.

How does Outline+ differ from Shape+ and Contour+?

Very little on paper. All three carry 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, are placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, and last 6 to 12 months. Outline+ is the one offered with a 29G needle option.

Mais de Prollenium Medical Technologies

Ver o laboratório →
* Produto de uso profissional. A embalagem pode variar consoante o lote ou o mercado. Consulte as instruções de utilização fornecidas para as indicações completas e as contraindicações.